March 3, 2020 / 2:13 PM / a month ago

BRIEF-RhoVac AB Says First Patient In Finland has Started Treatment In BRaVac Clinical Study

March 3 (Reuters) - RhoVac AB:

* RHOVAC AB - FIRST PATIENT IN FINLAND STARTED TREATMENT IN CO’S CLINICAL PHASE IIB STUDY IN PROSTATE CANCER, A STUDY ENTITLED RHOVAC-002

* RHOVAC AB - RESULTS REPORT ON ACTIVE TREATMENT PART OF RHOVAC-002 STUDY IS EXPECTED IN H2 2021 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below